Finding new collaboration models for enabling neglected tropical disease drug discovery.

Some of the best practices in industrial drug discovery, which include careful compound design, streamlined synthesis, compound assessment via a well-defined testing cascade, plus informatics implementation to interpret the experimental results, are now being applied to NTD drug discovery. This environment has produced credible, early-stage drug discovery programs that are more likely to produce new therapies for NTDs in the coming years and fill the pipelines within product development partnerships.